Bio-Rad Laboratories, Inc. Class A Common Stock vs Coursera Inc — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B), while Coursera Inc trades at $5.65 (market cap $1.50B). The key difference: Bio-Rad Laboratories, Inc. Class A Common Stock is far larger — about 6.3× Coursera Inc's market cap, and Bio-Rad Laboratories, Inc. Class A Common Stock is trading nearer its 52-week high, Coursera Inc nearer its low. Which is the better fit depends on your goals.
| BIO | COUR | |
|---|---|---|
Market Cap | $9.43B | $1.50B |
Sector | Health | Consumer Staples |
52-Week High | $356.25 | $12.20 |
52-Week Low | $241.71 | $5.09 |
Enterprise Value | $9.18B | $759.54M |
Trailing returns across standard periods
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →Coursera Inc is a global online learning platform that offers anyone, anywhere access to online courses and degrees from world-class universities and companies. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The platform will contain a catalog of high-quality content and credentials, content developed by leading university and industry partners, data and machine learning drive personalized Learning, effective marketing, and skills Benchmarking and others.
Read more on COUR →